Celcuity (NASDAQ:CELC) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Celcuity (CELC) operate in?

Celcuity is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Celcuity Stock (NASDAQ: CELC) stock price, news, charts, stock research, profile.

Open	$14.28
Close	$14.35
Volume / Avg.	220.46K / 409.46K
Day Range	$14.05 - $14.88
52 Wk Range	8.39 - 22.19
Market Cap	$531.38M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	38
Short Interest	7.87%
Days to Cover	9.31

Recent News

10 Short Squeeze Stocks To Watch: Yellow Corporation, Getty Images, Tupperware And More

Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a new focus of traders looking for the next huge move. High short interest and steep borrowing costs are among the common traits that could lead to a short squeeze.

Chris Katje

Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session

Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.

Lisa Levin

The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings

Here's a roundup of top developments in the biotech space over the last 24 hours:

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

Apr

May

Jul

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$14.28
Close	$14.35
Volume / Avg.	220.46K / 409.46K
Day Range	$14.05 - $14.88
52 Wk Range	8.39 - 22.19
Market Cap	$531.38M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	38
Short Interest	7.87%
Days to Cover	9.31

About Celcuity Inc

Sector

Health Care

Industry

Biotechnology

Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Compan...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Celcuity (CELC) stock?

You can purchase shares of Celcuity (NASDAQ:CELC) through any online brokerage.

View our list of the best stock brokerages

Who are Celcuity (CELC) competitors?

Other companies in Celcuity’s space includes: Valneva (NASDAQ:VALN), 4D Molecular Therapeutics (NASDAQ:FDMT), Altimmune (NASDAQ:ALT), Sage Therapeutics (NASDAQ:SAGE) and Pharming (NASDAQ:PHAR).

What is the forecast, or price target, for Celcuity (CELC) stock?

Celcuity has a consensus price target of $31.71.

What is the current price for Celcuity (CELC)?

The stock price for Celcuity (NASDAQ: CELC) is $14.35 last updated September 25, 2024 at 4:00 PM EDT.

Does Celcuity (CELC) pay a dividend?

There are no upcoming dividends for Celcuity.

When is Celcuity (NASDAQ:CELC) reporting earnings?

Celcuity’s Q3 earnings are confirmed for Monday, November 11, 2024.

Is Celcuity (CELC) going to split?

There is no upcoming split for Celcuity.

What sector and industry does Celcuity (CELC) operate in?

Celcuity is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Top Stock Ideas Sent Daily — Join and Gain Your Edge